SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

SciVision Biotech Reports Third-Quarter Net Profit of NT$23.0 Million

SciVision Biotech reported third-quarter net profit of NT$23.0 million, compared with NT$58.3 million a year earlier. Revenue was NT$202.671 million versus NT$221.410 million.

1786
SquawkNews Desk

SciVision Biotech Inc. - Taiwan 3rd Quarter ended Sept. 30: Figures in New Taiwan dollars. 2026 2025 Revenue NT$202,671,000 NT$221,410,000 Pretax Profit NT$24,252,000 NT$71,716,000 Net Profit…

Related stories

Deutsche Telekom Reports Higher Third-Quarter Profit The German telecommunications company reported a rise in profit in the third quarter. M impact | EQUITY | Nov 05, 2026, 08:08 AM UTC Stocks in United Kingdom Hit 12-week High GB100 increased to 10936.00 Index Points, the highest since August 2026. Over the past 4 weeks, United Kingdom Stock Market Index (GB100) gained 3.16%, and in the last 12 months, i L impact | EQUITY | Nov 05, 2026, 08:08 AM UTC ArrayPatch Completes €3.2 Million Seed Financing ArrayPatch said it completed an oversubscribed €3.2 million seed financing. M impact | EQUITY | Nov 05, 2026, 08:08 AM UTC Verbund shares fall 1.6% after results L impact | EQUITY | Nov 05, 2026, 08:07 AM UTC Hyundai Motor America recalls 37,901 U.S. vehicles M impact | EQUITY | Nov 05, 2026, 08:07 AM UTC T-Therapeutics Closes Oversubscribed $133 Million Series B Financing M impact | EQUITY | Nov 05, 2026, 08:06 AM UTC